IPN Hydrogel Drug Delivery for Toughness and Tunable Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hydrogel-based drug delivery systems for tendon injuries face challenges in mechanical toughness, drug storage instability, and the trade-off between loading capacity and tunable release, with oral and intravenous medications susceptible to denaturation and toxicity.
Innovation Solution
The development of interpenetrating networks (IPN) hydrogel compositions with a covalently crosslinked first polymer network and ionically or physically crosslinked second polymer network, incorporating therapeutic agents, which allow for sustained and tunable drug release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional hydrogels are used for drug delivery, then drug loading capacity can be increased, but mechanical toughness deteriorates
Solution Approach 1:
The patent employs a dual-network hydrogel composite structure where a first polymer network (e.g., alginate) provides high drug loading capacity through ionic crosslinking, while a second polymer network (e.g., polyacrylamide) contributes mechanical toughness through covalent crosslinking. This composite architecture allows both networks to coexist and contribute their respective strengths, resolving the contradiction between drug loading capacity and mechanical toughness.
2Quantity of substance
If traditional hydrogels are used for drug delivery, then loading capacity can be increased, but drug storage stability deteriorates
Solution Approach 1:
The dual-network hydrogel creates a composite matrix where the first polymer network (alginate) provides ionic crosslinking for high drug loading, while the second polymer network (polyacrylamide) provides covalent crosslinking for enhanced structural stability. This composite structure prevents drug leakage and maintains drug stability during storage, resolving the contradiction between loading capacity and storage stability.
3Duration of action of moving object
If traditional hydrogels are used for drug delivery, then extended release can be achieved, but tunable release control deteriorates
Solution Approach 1:
The patent implements dynamic release control by utilizing two distinct degradation mechanisms: the first polymer network degrades via ionic bond cleavage (controlling initial release), while the second polymer network degrades via covalent bond cleavage (controlling sustained release). This dynamic, multi-stage degradation profile enables both extended release duration and tunable release kinetics, resolving the contradiction between extended release and tunable control.
4Ease of operation
If oral or intravenous medications are used, then drug delivery can be achieved, but drug-induced toxicity increases
Solution Approach 1:
The dual-network hydrogel acts as an intermediary carrier that localizes drug delivery directly at the tendon injury site. The hydrogel matrix encapsulates the therapeutic agent and releases it locally through controlled degradation, preventing systemic circulation and subsequent toxicity. This local delivery approach maintains ease of administration while eliminating drug-induced toxicity associated with oral or intravenous routes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The IPN hydrogel compositions enable extended and controlled release of therapeutic agents, overcoming mechanical deficiencies and drug stability issues, facilitating local delivery to tendon tissues.
Implementation Method 1
a first polymer network that is covalently crosslinked
Implementation Method 2
a second polymer network that is ionically crosslinked
Implementation Method 3
the therapeutic agent is released from the IPN hydrogel composition in a sustained manner
Data Source
AI summary
Described herein are tough gel compositions that comprise an interpenetrating networks (IPN) hydrogel. The IPN hydrogel comprises a first polymer network (covalently crosslinked) and a second polymer network (ionically crosslinked), at least one therapeutic agent, and a clay material. The tough gel compositions may further include an adhesive polymer layer attached to the IPN hydrogel. Methods of use of these compositions, such as for extended release drug delivery, are also described.